文献速递膀胱癌与上尿路尿路上皮癌

吸烟与上尿路尿路上皮癌肾输尿管切除术后的较差生存结局相关

Smoking is Associated With Poorer Survival Outcomes Following Nephroureterectomy for Upper Tract Urothelial Cancer.
PubMed 文献 · Urology · 2025-08-21

任何吸烟史者总生存(OS)均劣于从不吸烟者,但膀胱内复发、对侧上尿路复发、转移及癌症特异性生存无显著差异。接受膀胱内化疗(IVC)的吸烟者膀胱内复发率与OS有所改善。

要点

  • 任何吸烟史的UTUC患者RNU术后总生存显著劣于从不吸烟者。
  • 吸烟状态与膀胱内复发、对侧上尿路复发、转移及癌症特异性生存无显著差异。
  • 吸烟者接受膀胱内化疗(IVC)者膀胱内复发率与OS改善。

核心结论

  • 有RNU治疗UTUC病史且有任何吸烟史的患者,总生存(OS)劣于无吸烟史者。
  • 吸烟状态与膀胱内复发、对侧上尿路复发、尿路上皮外复发及癌症特异性生存无显著差异。
  • 戒烟咨询仍是优化此类患者健康结局的重要持续照护要素。

研究设计与样本

  • 按吸烟史分为从不吸烟、<20包年、≥20包年三组,比较OS、癌症特异性生存、膀胱内复发、对侧上尿路复发及转移。

主要发现

  • 从不吸烟组OS显著更高,<20包年吸烟史者死亡风险比1.38(95%CI 1.09-1.73),≥20包年者1.34(95%CI 1.12-1.61),P=.002。
  • 按吸烟状态未发现膀胱内复发、对侧上尿路复发、转移或癌症特异性生存风险的显著差异。
  • 吸烟者中接受IVC者较未接受者膀胱内复发率与OS改善。

临床怎么用

  • 对UTUC患者应持续进行戒烟咨询,以优化RNU术后的整体健康结局。
  • 吸烟史可作为RNU术后总生存风险分层的参考因素。
  • 对吸烟的UTUC患者,可考虑膀胱内化疗以改善膀胱内复发与OS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the oncologic outcomes in patients treated for UTUC by radical nephroureterectomy (RNU) relative to their smoking history in a contemporary cohort that includes use of neoadjuvant and intravesical chemotherapy (IVC). METHODS: We analyzed a multi-institutional cohort of patients treated with RNU for UTUC between 2000 and 2020. Patients were classified as never smokers, those with a <20 pack-year smoking history, and those with a ≥20 pack-years of smoking history. Overall survival (OS), cancer-specific survival, intravesical recurrence, contralateral upper tract recurrence, and metastasis were compared. RESULTS: One thousand seven hundred ninety-six patients were included. No significant differences in the risks of intravesical recurrence, contralateral upper tract recurrence, metastasis, or cancer-specific survival were identified based on smoking status. OS was significantly higher in the never smoking group, with hazard ratio for death of 1.38 (95% CI 1.09-1.73) for <20 pack years smoking history and 1.34 (95% CI 1.12-1.61) for ≥20 pack years smoking history (P = .002). Rates of intravesical recurrence and OS were improved among smokers who received IVC compared to those who did not. CONCLUSION: Patients with a history of RNU for UTUC with any smoking history had worse OS compared to those with no smoking history, but no differences were seen in intravesical, contralateral upper tract, and extraurothelial recurrence or in cancer-specific survival. Counseling on smoking cessation remains an important element of ongoing care to optimize health outcomes in these patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Lehner K, Li R, Hensley PJ, et al. Smoking is Associated With Poorer Survival Outcomes Following Nephroureterectomy for Upper Tract Urothelial Cancer. Urology. 2025. PMID: 40848880. doi:10.1016/j.urology.2025.08.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。